4Lorenza Rimassa, Armando Santoro. The present and the future landscape of treatment of advanced hepatocellular carcinoma [J] . Digest Dis, 2010 ,42 (S3) : S273-S280. 被引量：1
5Osamu Kaneko, Lucy Gong,Jingli Zhang,et al. A binding domain on mesothelin for CAI25/MUCI6 [J]. J Bioi Chern, 2009,284 (6) : 3739-3749. 被引量：1
6Xiang X, Feng M, Felder M ,et al, HNI25:A novel immunoadbesin targeting MUCI6 with potential for cancer therapy [J]. J Cancer, 2011,2:280-291. 被引量：1
7Haridas D, Chakraborty S, Ponnusamy MP, et al. Pathobiological implications of MUCl6 expression in pancreatic cancer [J]. PloS One, 2011 ,6( 10) :e26839. 被引量：1
8Lakshmanan I, Ponnusamy MP, Das S, et al, MUCI6 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells [J]. Oncogene, 2012,31 (7) : 805-817. 被引量：1
9Houda Bouanene, Abdelhedi Miled. Conflicting views on the molecular structure of the cancer antigen CA125/MUCI6 [J]. Dis Markers, 2010 ,28: 385-394. 被引量：1
10Tang Z, Feng M, Gao W, et al, A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surface [J]. Mol Cancer Ther, 2013, 12( 4) : 416426. 被引量：1
